HIGHLIGHTS
- who: December and collaborators from the Medicine, Italy University, China have published the paper: Ef ciprofol-remifentanil versus propofol-remifentanil during beroptic bronchoscopy: A prospective, randomized, double-blind, non-inferiority trial, in the Journal: (JOURNAL)
- how: The authors designed this prospective randomized double-blind non-inferiority trial to explore the efficacy and safety of ciprofol-remifentanil versus propofol-remifentanil during FB. This trial was conducted in patients with ASA I-II.
SUMMARY
This procedure is invasive and painful (Kamel et_al, 2020; Wang W. H et_al, 2022). Each drug has limitations (Dal . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.